Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment

Clinical trials have confirmed that chimeric antigen receptor (CAR) T cell therapies are revolutionizing approaches for treating several relapsed or refractory hematological tumors. Cytokine release syndrome (CRS) is an adverse event with high incidence during CAR-T treatment. A further understandin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Yan, Zhiling, Zhang, Huanxin, Cao, Jiang, Zhang, Cheng, Liu, Hui, Huang, Hongming, Cheng, Hai, Qiao, Jianlin, Wang, Ying, Wang, Yan, Gao, Lei, Shi, Ming, Sang, Wei, Zhu, Feng, Li, Depeng, Sun, Haiying, Wu, Qingyun, Qi, Yuekun, Li, Hujun, Wang, Xiangmin, Li, Zhenyu, Liu, Hong, Zheng, Junnian, Qian, Wenbin, Zhang, Xi, Xu, Kailin
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940756/
https://ncbi.nlm.nih.gov/pubmed/33708205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.611366
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados